Strides Pharma suspends sale Ranitidine tablets in US
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Strides Pharma suspends sale of Ranitidine tablets in US

10:29 AM, 27th September 2019
Strides Pharma  logo

NEW DELHI, INDIA: Strides Pharma Science has suspended the sale of Ranitidine tablets after it received an information request from the US health regulator to provide test data related to impurities in the drug. Ranitidine tablets are used to treat peptic ulcers of the stomach and intestines.

Data related to N-nitrosodimethylamine impurities is to be provided to the agency in 30 days.

"While the company conducts the relevant tests mandated by the the United States Food and Drug Administration (USFDA), it has suspended sales of Ranitidine tablets in the US market until such time it has clarity of next steps as would be indicated by the USFDA," Strides Pharma Science said in a BSE filing.

The company said it predominantly sells Ranitidine tablets in the US markets, and its front end sales globally for the product stood at USD 9 million in the first half of the current financial year.

Ranitidine tablets is amongst the top 5 products sold by the company in the USA.

Strides Pharma Science said in spite of this temporary suspension of the Ranitidine supplies, the company retains its growth outlook for the current financial year for the US markets.

The company's shares were trading 4.61 per cent lower at Rs 313.45 apiece on the BSE.

Source: PTI 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Arkema acquires full ownership in Taixing Sunke Chemicals JV

COLOMBES, FRANCE: Arkema has completed the acquisition of its partner’s stake in Taixing Sunke Chemicals Co. Ltd.  Taixing Sunke Chemicals ...

Read more
BASF acquires Isobionics; Enters natural flavors & fragrances market

LUDWIGSHAFEN, GERMANY: BASF acquires Isobionics, an innovation leader in biotechnology which is serving the global market for natural flavors & fr ...

Read more
ExxonMobil to sell Norwegian upstream operations for $4.5 billion

IRVING, US: ExxonMobil signed an agreement to sell its non-operated upstream assets in Norway for $4.5 billion to Var Energi AS. This is part of its ...

Read more
BASF increases neopentyl glycol capacity at Verbund site, Germany

LUDWIGSHAFEN, GERMANY: BASF SA has increased the capacity of its neopentyl glycol (NPG) plant at the Verbund site in Ludwigshafen, Germany, by 10,000 ...

Read more
Clariant partners with Merck & Sabic to improve recyclability of PE film

MUTTENZ, SWITZERLAND: Clariant has teamed up with Merck KGaA and Sabic to develop laser-marking technology and materials to ease the recycling process ...

Read more
Grace licenses Unipol technology to BPCL

COLUMBIA, US: W R Grace & Co has licensed its Unipol PP Process Technology to Bharat Petroleum Corporation Limited (BPCL).  Located in ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X